These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 728192)

  • 1. Studies on the mutagenicity of N-hydroxy-2-acetylaminofluorene in the Ames-Salmonella mutagenesis test system.
    Andrews LS; Hinson JA; Gillette JR
    Biochem Pharmacol; 1978; 27(20):2399-408. PubMed ID: 728192
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat.
    Schut HA; Wirth PJ; Thorgeirsson SS
    Mol Pharmacol; 1978 Jul; 14(4):682-92. PubMed ID: 683178
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver.
    Wirth PJ; Thorgeirsson SS
    Mol Pharmacol; 1981 Mar; 19(2):337-44. PubMed ID: 6939968
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of in vitro mutagenic activation and covalent binding of N-hydroxy-2-acetylaminofluorene in isolated liver cell nuclei from rat and mouse.
    Sakai S; Reinhold CE; Wirth PJ; Thorgeirsson SS
    Cancer Res; 1978 Jul; 38(7):2058-67. PubMed ID: 26463
    [No Abstract]   [Full Text] [Related]  

  • 5. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA; Andrews LS; Gillette JR
    Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells.
    Glatt H; Oesch F
    Mutat Res; 1985 Apr; 149(2):265-9. PubMed ID: 3885026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative electrophilicity, mutagenicity, DNA repair induction activity, and carcinogenicity of some N- and O-acyl derivatives of N-hydroxy-2-aminoflourene.
    Bartsch H; Malaveille C; Stich HF; Miller EC; Miller JA
    Cancer Res; 1977 May; 37(5):1461-7. PubMed ID: 322856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
    Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM
    Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenicity of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin and their respective deacetylated metabolites in nitroreductase deficient Salmonella TA98FR and TA100FR.
    Wirth PJ; Alewood P; Calder I; Thorgeirsson SS
    Carcinogenesis; 1982; 3(2):167-70. PubMed ID: 6896016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N'-hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation.
    Stout DL; Baptist JN; Matney TS; Shaw CR
    Cancer Lett; 1976 May; 1(5):269-74. PubMed ID: 797443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.
    Beranek DT; White GL; Heflich RH; Beland FA
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5175-8. PubMed ID: 6752940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial mutagenesis and host cell DNA damage by chemical carcinogens in the Salmonella/hepatocyte system.
    Staiano N; Erickson LC; Thorgeirsson SS
    Biochem Biophys Res Commun; 1980 Jun; 94(3):837-42. PubMed ID: 6994733
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats.
    Schut HA; Thorgeirsson SS
    Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509
    [No Abstract]   [Full Text] [Related]  

  • 14. Comutagenic effect of norharman and harman with 2-acetylaminofluorene derivatives.
    Umezawa K; Shirai A; Matsushima T; Sugimura T
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):928-30. PubMed ID: 345280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the mutagenicity of carcinogenic arylamines by ethinyl estradiol.
    Purdy RH; Marshall MV
    Carcinogenesis; 1984 Dec; 5(12):1709-15. PubMed ID: 6499122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic activation of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in subcellular fractions from X/Gf mice.
    Reddy TV; Weisburger EK; Thorgeirsson SS
    J Natl Cancer Inst; 1980 Jun; 64(6):1563-9. PubMed ID: 6929392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic activation of N-hydroxy-2-acetylaminofluorene by developing epithelial cells of rat small intestine and effects of antioxidants.
    Schut HA; Thorgeirsson SS
    J Natl Cancer Inst; 1979 Dec; 63(6):1405-9. PubMed ID: 292812
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutagenicity of 7-iodo and 7-fluoro derivatives of N-hydroxy-and N-acetoxy-N-2-acetylaminofluorene in the Salmonella typhimurium assay.
    Santella RM; Fuchs RP; Grunberger D
    Mutat Res; 1979 May; 67(1):85-7. PubMed ID: 379638
    [No Abstract]   [Full Text] [Related]  

  • 19. Alterations in the transcriptional capacity of hepatic DNA-dependent RNA polymerase I and II by N-hydroxy-2-acetylaminofluorene.
    Glazer RI
    Cancer Res; 1976 Jul; 36(7 PT 1):2282-9. PubMed ID: 1277132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by diacylmethane derivatives of mutagenicity and nucleic acid binding of 2-aminofluorene derivatives.
    Wang CY; Lee MS; Nagase H; Zukowski K
    J Natl Cancer Inst; 1989 Nov; 81(22):1743-7. PubMed ID: 2681797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.